We are live on ! Find out more
PROF

Profound Medical

56 hedge funds and large institutions have $170M invested in Profound Medical in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 4

38% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 13

38% more capital invested

Capital invested by funds: $124M → $170M (+$46.8M)

27% more call options, than puts

Call options by funds: $2.5M | Put options by funds: $1.97M

24% more funds holding

Funds holding: 4556 (+11)

5.75% more ownership

Funds ownership: 36.34%42.09% (+5.7%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
56
Holders Change
+11
Holders Change %
+24.44%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
18
Reduced
13
Closed
4
Calls
$2.5M
Puts
$1.97M
Net Calls
+$524K
Net Calls Change
+$205K

PROF Hedge Fund Activity: Q4 2020 in Review

56 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q4 2020, worth a combined $170M — up 38% from $124M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new PROF positions and 4 closed out — a net gain of 11 holders — while 18 added to existing stakes and 13 trimmed.

The largest buyer was Letko, Brosseau & Associates, adding an estimated $14.6M. The largest seller was Park West Asset Management, exiting entirely with an estimated $7.94M sold.

  • 56 institutional investors held Profound Medical (PROF) as of Q4 2020, up from 45 in Q3 2020.
  • Funds reported $170M of Profound Medical stock for Q4 2020, up 38% quarter-over-quarter.
  • 15 funds opened new Profound Medical positions in Q4 2020 and 4 closed out, a net change of +11 holders.
  • The largest Profound Medical buyer in Q4 2020 was Letko, Brosseau & Associates, an estimated $14.6M added.
  • The largest Profound Medical seller in Q4 2020 was Park West Asset Management, an estimated $7.94M sold.

Based on aggregated 13F filings for Q4 2020.